Government Affairs
Refine Search
Biotechnology
Marking International Clinical Trials Day 2012 (May 20), Australian biotech industry trade group AusBiotech has called on the government to complete the Clinical Trials Action Group (CTAG) change program, to strengthen Australian's position as a destination for clinical trials. 22 May 2012
Biotechnology
Despite increasing budget pressures, countries around the world are making substantial investments in pro-innovation policies and programs to lure the biopharmaceutical research sector away from the US, according to a new study released by Battelle Technology Partnership Practice last week. 20 May 2012
Pharmaceutical
A collaboration of the US National Institutes of Health (NIH), Banner Alzheimer's Institute (BAI), University of Antioquia in Colombia and Swiss drug major Roche's (ROG: SIX) subsidiary Genentech has announced the first-ever prevention trial in cognitively healthy individuals who are destined to develop Alzheimer's disease because of their genetic history. 17 May 2012
Generics
The European Union Parliament Committee on Development released its draft opinion this week on the Anti-Counterfeiting Trade Agreement (ACTA), which will be voted on next Monday (May 14). Medecins Sans Frontieres (MSF) believes that this draft opinion is still fundamentally flawed and should not be accepted or signed by the EU and its member states in its current form. 11 May 2012
Pharmaceutical
The adverse effects of medicinal products will be better monitored in future, to prevent the recurrence of cases like the French diabetes drug Mediator (benfluorex), which led to many deaths. Changes to existing European Union legislation, backed by the Public Health Committee on Tuesday, would trigger an automatic EU safety evaluation in the event of a safety alert about a medicinal product in any EU member state. 10 May 2012
Biotechnology
In a web site posting last week, The US Center for Medicare and Medicaid Services (CSM) announced that manufacturers will not be required to collect data under the physician payment Sunshine provisions of the Patient Protection and Affordable Care Act before next January. 8 May 2012
Biotechnology
After years of consistent growth, the German biopharmaceuticals market came to a juddering halt last year. Turnover stagnated at around 5.4 billion euros ($7.13 billion), noted Frank Mathias, chairman of VFA bio and chief executive of biotech firm MediGene, as he introduced this year's report on medicinal biotechnology in Germany compiled by Boston Consulting Group. 30 April 2012
Biotechnology
US trade group the Biotechnology Industry Organization (BIO) has submitted a statement for the record to the House Ways and Means Subcommittee on Select Revenue Measures for a hearing on "Certain Expiring Tax Provisions." 29 April 2012
Biotechnology
US Senators Richard Burr (Republican, North Carolina) and Tom Coburn (Republican, Oklahoma) this week introduced the Promoting Accountability, Transparency, Innovation, Efficiency and Timeliness at FDA (PATIENTS' FDA) Act, a bill to help make sure that the Food and Drug Administration fulfills its mission to ensure that patients have access to cutting-edge, life-saving drugs and devices as quickly as possible. 19 April 2012
Generics
A bill giving generic drug manufacturers in the USA the authority to revise labeling for their products when they become aware of risks that are not adequately disclosed would fill a hazardous hole in drug regulation, consumer advocacy group Public Citizen said in a letter sent to Senate Judiciary Committee Chairman Patrick Leahy, who introduced the Patient Safety and Generic Labeling Improvement Act this week. 19 April 2012
Pharmaceutical
The South African government has announced the designation of certain pharmaceutical products for domestic production. The announcement that was made by Trade and Industry Minister, Rob Davies in Pretoria, is the second wave of the designation and is in line with the amended Regulations to the Preferential Procurement Policy Framework Act (PPPFA). 16 April 2012
Pharmaceutical
As a result of government bureaucracies to approve new prescription drugs for public use, Canadians are waiting nearly two-and-a-half years, according to a new report from the Fraser Institute, the leading public policy think-tank in Canada. 9 April 2012
Pharmaceutical
New research reveals that the pharmaceutical industry lobby is spending more than 40 million euros ($530.5 million) annually to influence decision making in the European Union - of which nearly half is spent by drug manufacturers on in-house lobbyists. 29 March 2012
Generics
Health-related consumer groups Health Action International (HAI) Europe, Oxfam, Medecins Sans Frontieres (MSF) and the Trans Atlantic Consumer Dialogue (TACD) have issued a call for European Union parliamentarians to condemn the Anti-Counterfeiting Trade Agreement ( ACTA) independently of the European Court of Justice (ECJ) referral. 27 March 2012
Generics
Ranking US Congress Member Henry Waxman, Health Subcommittee Ranking Member Frank Pallone, Representative John Dingell, Health Subcommittee Chairman Joe Pitts and Rep. Tim Murphy last month introduced HR 3988, titled the Generic Drug and Biosimilar User Fee Act of 2012. 6 March 2012
Pharmaceutical
The Greek pharmaceutical industry association, the SFEE, says that pharmaceutical companies may go out of business in the event of a 'haircut' of the bonds they have acquired in settlement of overdue hospital debts. There is a noticeable risk of shortages in the supply of medicine. 27 February 2012
Generics
A UK Department of Health released yesterday endorses the current voluntary agreement between the DoH and the pharmaceutical industry and confirms that UK medicines are representing good value for money for the National Health Service. 24 February 2012
Pharmaceutical
While overall welcoming the recent Korea-USA Free Trade Agreement (FTA), the Pharmaceutical Research and Manufacturers of America (PhRMA) says it still has some reservations about the accord. 23 February 2012
Pharmaceutical
Responding to US President Barack Obama's fiscal year 2013 budget proposals, Pharmaceutical Research and Manufacturers of America (PhRMA) president and chief executive John Castellani argues that, despite his many pronouncements to support innovation, advance biomedical research, promote job creation and control health care costs for seniors, this 2013 budget proposal flies in the face of these important goals. 15 February 2012
Pharmaceutical
Backed by government support and private sector investment, the Russian pharmaceutical market is likely to expand at a compound annual growth rate (CAGR) of 13% during 2011-2013,to reach a value of $25,68 billion at the end of the period, according to a new report from market analysts RNCOS. 13 February 2012
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze